The CCR4-NOT complex is a tumor suppressor in Drosophila melanogaster eye cancer models

Bibliographic Details
Title: The CCR4-NOT complex is a tumor suppressor in Drosophila melanogaster eye cancer models
Authors: Carmen Vicente, Rocco Stirparo, Sofie Demeyer, Charles E. de Bock, Olga Gielen, Mardelle Atkins, Jiekun Yan, Georg Halder, Bassem A. Hassan, Jan Cools
Source: Journal of Hematology & Oncology, Vol 11, Iss 1, Pp 1-16 (2018)
Publisher Information: BMC, 2018.
Publication Year: 2018
Collection: LCC:Diseases of the blood and blood-forming organs
LCC:Neoplasms. Tumors. Oncology. Including cancer and carcinogens
Subject Terms: CCR4-NOT, Leukemia, mRNA stability, Tumor suppressor, Drosophila melanogaster, Diseases of the blood and blood-forming organs, RC633-647.5, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282
More Details: Abstract Background The CNOT3 protein is a subunit of the CCR4-NOT complex, which is involved in mRNA degradation. We recently identified CNOT3 loss-of-function mutations in patients with T-cell acute lymphoblastic leukemia (T-ALL). Methods Here, we use different Drosophila melanogaster eye cancer models to study the potential tumor suppressor function of Not3, the CNOT3 orthologue, and other members of the CCR4-NOT complex. Results Our data show that knockdown of Not3, the structural components Not1/Not2, and the deadenylases twin/Pop2 all result in increased tumor formation. In addition, overexpression of Not3 could reduce tumor formation. Not3 downregulation has a mild but broad effect on gene expression and leads to increased levels of genes involved in DNA replication and ribosome biogenesis. CycB upregulation also contributes to the Not3 tumor phenotype. Similar findings were obtained in human T-ALL cell lines, pointing out the conserved function of Not3. Conclusions Together, our data establish a critical role for Not3 and the entire CCR4-NOT complex as tumor suppressor.
Document Type: article
File Description: electronic resource
Language: English
ISSN: 1756-8722
Relation: http://link.springer.com/article/10.1186/s13045-018-0650-0; https://doaj.org/toc/1756-8722
DOI: 10.1186/s13045-018-0650-0
Access URL: https://doaj.org/article/d2b4f3970332452b81f7d13001aa3d14
Accession Number: edsdoj.2b4f3970332452b81f7d13001aa3d14
Database: Directory of Open Access Journals
Full text is not displayed to guests.
More Details
ISSN:17568722
DOI:10.1186/s13045-018-0650-0
Published in:Journal of Hematology & Oncology
Language:English